23948sdkhjf
Logga in eller skapa en prenumeration för att spara artiklar
Få tillgång till allt innehåll på Life Science Sweden
Ingen bindningstid eller kortinformation krävs
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
Annons
Annons
Innehållet nedan modereras inte i förväg och omfattas därmed inte av webbplatsens utgivningsbevis.
Dela sida
Sponsrat innehåll

Are you prepared for the updated ISO 10993 1:2025?

The latest edition of ISO 10993-1 reinforces the integration of biological evaluation with risk management, introduces updated approaches to exposure assessment, strengthens expectations for material and chemical characterization, and reorganizes biological effect endpoints across the standard.

Overall, evaluations will become more risk-driven, chemistry-focused, and justification-intensive, potentially requiring reassessment of legacy devices. These updates may affect your current biological evaluations and technical documentation.

To support you, we can perform a comprehensive gap analysis of your current biological evaluation against the new ISO 10993‑1 requirements.

Our experts can help you:
• Identify gaps in your existing documentation and processes
• Understand what the updated biological effects tables mean for your device
• Plan the updates needed to stay compliant and audit ready

Contact us to learn how we can support you with a smooth transition to ISO 10993‑1:2025.

Aurevia
Box 150 27
750 15 Uppsala
Uppsala kommun
Sverige
VAT nummer: SE5565873147

Kontaktperson

Anna-Karin Alm
Head of QARA
anna-karin.alm@aurevia.com
Annons Annons
BREAKING
{{ article.headline }}
0.045|